prescription drugs

Drugmakers Blamed for Blocking Generics Have Jacked Up Prices , Cost U.S. Billions

An analysis shows that drug companies that may have worked delay the entrance of cheaper competitors onto the market, which resulted in higher prices and cost taxpayers more money over time.

Makers of brand-name drugs called out by the Trump administration for potentially stalling generic competition have hiked their prices by double-digit percentages since 2012 and cost Medicare and Medicaid nearly $12 billion in 2016, a Kaiser Health News analysis has found.

Poll Finds Majority Of Americans Want Restraints On Drug Prices

An overwhelming majority of Americans favor government action to restrain prescription drug prices, according to a poll released Thursday.

Eighty-two percent of those polled said they want Medicare to negotiate prices with the companies, which Congress does not allow. Seventy-eight percent favored limiting the amount companies can charge for high-cost drugs, such as those that fight cancer or hepatitis, according to the poll from the Kaiser Family Foundation.

Pages

Subscribe to prescription drugs